INSM Q1 2024 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M+15.8% YoY

Gross Profit

$58M76.9% margin

Operating Income

-$146M-192.7% margin

Net Income

-$157M-208.1% margin

EPS (Diluted)

$-1.06

QoQ Revenue Growth

-9.8%

Cash Flow

Operating Cash Flow

-$184M

Free Cash Flow

-$189M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$1.6B

Stockholders' Equity

-$465M

Cash & Equivalents

$596M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$65M	+15.8%
Gross Profit	$58M	$51M	+13.0%
Operating Income	-$146M	-$148M	+1.8%
Net Income	-$157M	-$160M	+1.7%

Geographic Segments

UNITED STATES

$56M75%

JAPAN

$15M20%

Europe And The Rest Of The World

$4M6%